Vedolizumab Antibody
Vedolizumab is a humanized monoclonal antibody designed to selectively inhibit the α4β7 integrin. It is used in research to study mechanisms and therapeutic strategies for inflammatory bowel diseases, including in vitro adhesion assays and in vivo models of Crohn's disease and ulcerative colitis.
Product Specifications
Product Name Alternative
Vedolizumab, Integrin
Target
Integrin
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
4.89 mg/mL
Purity
98.40% (May vary between batches)
Molecular Weight
146.80 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNUM1907-50 1x 50 µL
STAT3 / Signal Transducer and Activator of Transcription 3 (PCRP-STAT3-2F12), BSA-free, 1 mg/mL
Sign In for Pricing
View Details 
GTR15140835 1 Vial
Lentiviral human CERK shRNA (UAS) - Lentiviral human CERK shRNA (UAS, iRFP) (100)
Sign In for Pricing
View Details 
GTR15100471 1 Vial
Lentiviral human ALG9 shRNA (UAS) - Lentiviral human ALG9 shRNA (UAS) plasmid
Sign In for Pricing
View Details 